policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
Iowa State confers Stange, Switzer awards
Four alumni of the Iowa State University College of Veterinary Medicine were honored Oct. 29, 2016.
JAVMA news
FDA extends call for treatment limit ideas
Food and Drug Administration authorities have extended a call for ideas on how to limit durations of some approved antimicrobial treatments in…
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
1935 - 1945
Information on food-producing animals was a mainstay of JAVMA during this decade.
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
Veterinary faculty among 2019 elected AAAS fellows
Three faculty at U.S. veterinary colleges are among 443 fellows chosen this past year by the American Association for the Advancement of Science. The…
JAVMA news
Robertson honored for achievements in microbiology
The 95th annual meeting of the Conference of Research Workers in Animal Diseases, Dec. 7-9, 2014, in Chicago honored Donald C. Robertson, PhD